Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2026 -2.718M
September 30, 2025 -1.185M
March 31, 2025 -0.8691M
September 30, 2024 -2.098M
March 31, 2024 -1.152M
September 30, 2023 0.4909M
March 31, 2023 1.723M
September 30, 2022 1.763M
March 31, 2022 1.547M
September 30, 2021 0.8521M
March 31, 2021 2.366M
September 30, 2020 2.449M
March 31, 2020 -0.0928M
September 30, 2019 -0.1696M
March 31, 2019 -0.3534M
September 30, 2018 0.4921M
March 31, 2018 -0.0348M
September 30, 2017 -0.8328M
March 31, 2017 -0.3581M
September 30, 2016 -2.259M
March 31, 2016 -2.218M
September 30, 2015 -2.036M
March 31, 2015
September 30, 2014
March 31, 2014 -5.401M
Date Value
September 30, 2013 -6.615M
March 31, 2013 -11.08M
September 30, 2012 -13.68M
March 31, 2012 -11.18M
September 30, 2011 -9.695M
March 31, 2011 -9.155M
September 30, 2010 -6.685M
March 31, 2010 -5.625M
September 30, 2009 -5.006M
March 31, 2009 -5.138M
September 30, 2008 -4.518M
March 31, 2008
August 31, 2007
February 28, 2007
August 31, 2006 -9.764M
February 28, 2006 -7.691M
August 31, 2005 -6.336M
February 28, 2005 -10.08M
August 31, 2004 -10.35M
February 29, 2004 -6.533M
August 31, 2003 -5.704M
February 28, 2003 -8.593M
August 31, 2002 -6.848M
February 28, 2002 -3.950M
August 31, 2001 -3.767M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Proteome Sciences Plc --
Oxford BioDynamics Plc -10.10M
ICON plc 1.083B
Champions Oncology, Inc. -5.564M
Silence Therapeutics Plc -41.79M